Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Biotech
AbbVie flags $2.7B R&D hit to brace investors for lower profit
AbbVie has warned investors that it expects to take a $2.7 billion hit tied to acquired in-process research and development expenses and milestones.
Nick Paul Taylor
Oct 6, 2025 3:27am
Medtronic to eye M&A, efficiencies after activist investor stake
Aug 19, 2025 11:26am
New Vicarious CEO pushes back surgical robot timeline
Aug 14, 2025 1:30pm
Fierce Pharma
New Incyte CEO takes 'fresh look' at business, outlines BD plan
Aug 4, 2025 11:16am
Baxter cuts financial forecasts, pauses infusion pump shipments
Aug 1, 2025 12:00pm
Fierce Pharma
BMS touts commercial execution, reckons with clinical setbacks
Jul 31, 2025 11:10am
